Moderate to Severe COVID-19
1 clinical trials · Condition
◉ Watch Moderate to Severe COVID-19
| Record | Firm | Date |
|---|---|---|
| Efficacy and Safety of JT001 (VV116) Compared With Favipiravir (NCT05279235) | Shanghai Vinnerna Biosciences Co., Ltd. | 2022-03-14 |
Track Moderate to Severe COVID-19 automatically
Every clearance here is in the API, with alerts when new ones post.